Alere Company

Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.

Connections from

Last Funding Type: Post-IPO Equity
Headquarters: Waltham, Massachusetts, United States
Total Funding: $512 000 000
Funding Status: M&A
Industry: Diagnostics
Technology: Genetic Test & Molecular Diagnostics
Estimated Revenue: $1B to $10B
Last Funding Date: 2017-08-14
Founded Date: 01.01.1981